Tapinarof cream 1% once daily for the treatment of plaque psoriasis: Patient-reported outcomes from the PSOARING 3 trial.

Bagel, Jerry; Gold, Linda Stein; Del Rosso, James; Johnson, Sandy; Yamauchi, Paul; Brown, Philip M; Bhatia, Neal; Moore, Angela Yen; Tallman, Anna M

Bagel, Jerry; Gold, Linda Stein; Del Rosso, James; Johnson, Sandy; Yamauchi, Paul; Brown, Philip M; Bhatia, Neal; Moore, Angela Yen; Tallman, Anna M.

Afiliación

Bagel J; Psoriasis Treatment Center of New Jersey, East Windsor, New Jersey. Electronic address: dreamacres1@aol.com.
Gold LS; Department of Dermatology, Henry Ford Health System, Detroit, Michigan.
Del Rosso J; JDR Dermatology Research/Thomas Dermatology, Las Vegas, Nevada.
Johnson S; Johnson Dermatology, Fort Smith, Arkansas.
Yamauchi P; Dermatology Institute & Skin Care Center, Santa Monica, California.
Brown PM; Dermavant Sciences, Inc, Morrisville, North Carolina.
Bhatia N; Therapeutics Clinical Research, San Diego, California.
Moore AY; Arlington Center for Dermatology, Arlington Research Center, Arlington, Texas; Baylor University Medical Center, Dallas, Texas.
Tallman AM; Dermavant Sciences, Inc, Morrisville, North Carolina.

J Am Acad Dermatol ; 89(5): 936-944, 2023 Nov.

Article en En | MEDLINE | ID: mdl-37172733

Palabras clave

PSOARING 3 trial; aryl hydrocarbon receptor (AhR) agonist; patient satisfaction; patient-reported outcomes; plaque psoriasis; quality of life; tapinarof cream 1% once daily; topical therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Am Acad Dermatol Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: J Am Acad Dermatol Año: 2023 Tipo del documento: Article